Home › Funds › Focused Investors LLC › ELV
Focused Investors LLC position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Focused Investors LLC reported holding 387,100 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$150.5M, representing 6.24% of its reported portfolio and ranking #5 among its reported holdings. Focused Investors LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Focused Investors LLC's ELV position evolved
Focused Investors LLC first disclosed a stake in ELV in Q3 2023 at 466,250 shares (US$203.0M). The position peaked in Q3 2024 at 501,600 shares, worth US$260.8M. Across 13 filings, Focused Investors LLC increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 387,100 shares valued at US$150.5M — a reduction of -74,500 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 466.25K | $203.01M | New |
| Q4 2023 | 460.55K | $217.18M | Reduce |
| Q1 2024 | 481.90K | $249.88M | Add |
| Q2 2024 | 468.10K | $253.64M | Reduce |
| Q3 2024 | 501.60K | $260.83M | Add |
| Q4 2024 | 517.80K | $191.02M | Add |
| Q1 2025 | 505.20K | $219.74M | Reduce |
| Q2 2025 | 514.90K | $200.28M | Add |
| Q3 2025 | 536.60K | $173.39M | Add |
| Q4 2025 | 522.70K | $183.23M | Reduce |
| Q1 2026 | 509.80K | $149.24M | Reduce |
| Q2 2026 | 461.60K | $178.51M | Reduce |
| Q3 2026 | 387.10K | $150.51M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.27B · Q3 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- First Eagle Investment Management 4.20M sh · $1.63B · Q3 2026
- Artisan Partners Limited Partnership 3.76M sh · $1.46B · Q3 2026
More on Focused Investors LLC
FAQ
How long has Focused Investors LLC held ELV?
Focused Investors LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Focused Investors LLC's current position in ELV?
As of Q3 2026, Focused Investors LLC holds 387.10K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $150.51M, representing 6.24% of its reported portfolio and ranking #5.
Has Focused Investors LLC been buying or selling ELV?
In the latest 13F filing (Q3 2026), Focused Investors LLC reduced its position in ELV. The position peaked in Q3 2024 at 501.60K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.